Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Double-Blind, Two-Dose, Placebo-Controlled Multicentre Study of 4-Hydroxy Tamoxifen Gel for Cyclical Mastalgia in Otherwise Healthy Pre-Menopausal Women With Regular Menstrual Cycles.

NCT00272714 is registered in ClinicalTrials.gov with ASCEND Therapeutics as lead sponsor.

NCT NCT00272714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00272714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Double-Blind, Two-Dose, Placebo-Controlled Multicentre Study of 4-Hydroxy Tamoxifen Gel for Cyclical Mastalgia in Otherwise Healthy Pre-Menopausal Women With Regular Menstrual Cycles.
Lead sponsor
ASCEND Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2003
Completion date
April 30, 2005
Enrollment
146 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cyclic breast pain, cyclic mastalgia